Kuros Biosciences AG (SWX:KURN)

Kuros Biosciences AG Revenue

In the year 2025, Kuros Biosciences AG had annual revenue of $146.06M USD with 71.51% growth. Kuros Biosciences AG had revenue of $82.58M in the half year ending December 31, 2025.

• Revenue: $146.06M
• Revenue Growth: +71.51%
• P/S Ratio: 6.20
• Revenue / Employee: $820.55K
• Employees: 178
• Market Cap: 718.19M CHF

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	146.06M	60.90M	71.51%
Dec 31, 2024	85.16M	45.30M	113.65%
Dec 31, 2023	39.86M	20.41M	104.92%
Dec 31, 2022	19.45M	4.30M	28.35%
Dec 31, 2021	15.15M	10.59M	231.96%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 22, 2026

Data Sources Report a data error